Nicholas S Peters

Title: Innovations by Nicholas S. Peters in Cardiac Treatment

Introduction

Nicholas S. Peters is a notable inventor based in Farnham Common, GB. He has made significant contributions to the field of cardiac treatment, particularly in the management of cardiac arrhythmias. With a total of 2 patents to his name, his work focuses on innovative methods to improve patient outcomes in cardiac care.

Latest Patents

One of Nicholas S. Peters' latest patents addresses the treatment of cardiac arrhythmia by modifying neuronal signaling through fat pads of the heart. This innovative approach aims to control cardiac arrhythmias, such as atrial fibrillation, particularly in post-operative settings. The patent describes the introduction of various non-ablative agents, including polymers, fibroblasts, neurotoxins, and growth factors, into one or more cardiac fat pads. These agents are introduced into the atrioventricular nodal fat pad, which is in proximity to the autonomic ganglia. The technique for introducing these agents can vary, including injection methods. Additionally, the sinoatrial nodal fat pad target site and the atrioventricular nodal fat pad target site are identified using a stimulator, which may have electrodes coupled to it or may be integrated into a delivery system.

Career Highlights

Nicholas S. Peters is associated with Cardiopolymers, Inc., where he continues to develop and refine his innovative approaches to cardiac treatment. His work is characterized by a commitment to advancing medical technology and improving patient care.

Collaborations

Some of his notable coworkers include Mark Maciejewski and Todor N. Mazgalev, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Nicholas S. Peters stands out as an inventor dedicated to enhancing cardiac treatment through innovative methods. His patents reflect a deep understanding of the complexities of cardiac arrhythmias and a commitment to improving patient outcomes.